A study at the Dana-Farber Cancer Institute in Boston, were focused to see if there was any effect of aspirin on prostate cancer outcomes.
The findings are contained in a letter published in the Dec. 27 issue of the New England Journal of Medicine and reveal that men undergoing hormone therapy for prostate cancer who take baby aspirin to protect their heart run a significantly higher risk of dying.
No User Responded In This Post
Leave Your Comments Here...